- Home
- Products
- Customized FluoroAb™
- APP
- Ponezumab-Cy3
Ponezumab-Cy3 (CAT#: ADC-FL-194)
- TARGET
- ANTIBODY
- DYE
- Name
- APP
- Alternative Names
- APP; amyloid beta (A4) precursor protein; AD1, Alzheimer disease; amyloid beta A4 protein; peptidase nexin II; preA4; protease nexin-II; peptidase nexin-II; beta-amyloid peptide; alzheimer disease amyloid protein; cerebral vascular amyloid peptide; AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; CTFgamma;
- Overview
- This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene.
- Overview
- Humanized Anti-APP IgG2-kappa antibody, Ponezumab
- Generic name
- Ponezumab
- Species Reactivity
- Human
- Name
- Cy3
- Color
- Orange
- Excitation⁄Emission (nm)
- 554/568
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-194. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-702 | Anti-APP (Solanezumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-701 | Anti-APP (Solanezumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-708 | Anti-APP (Bapineuzumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-710 | Anti-APP (Ponezumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-707 | Anti-APP (Bapineuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-IL6 MAb (Clone 6)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16148)
- Anti-SAIL MAb (Clone 1)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6672)
- Anti-FGFR2 MAb (Clone 6)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14098)
- Anti-CCR5 MAb (Clone 2)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8788)
- Anti-CEACAM6 MAb (Clone 3)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4300)
- Anti-ITGAL MAb (Clone 2)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5985)
- Anti-CD79B MAb (Clone 13)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2391)
- Toralizumab-iFluor 680 (CAT#: ADC-FL-802)
- Anti-IL13 MAb (Clone 2)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS619)
- Anti-IL17A MAb (Clone 4)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15153)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
